Paper Published: Comprehensive Review of Black-Box Optimization in Life Sciences Published in Allergology International
On September 22, 2025, Epistra and collaborators published a comprehensive review paper titled “Black-box optimization in immunology and beyond: A practical guide to algorithms and future directions” in the international journal Allergology International.
Paper Overview
In life science experiments, each trial incurs significant cost and time. Efficient experimental design that leverages past data has become increasingly important, and in recent years, black-box optimization (BBO) has attracted attention as a solution, with growing applications in both academia and industry.
BBO-related methods — Bayesian optimization, DBTL, active learning, iterative screening, and directed evolution — have often been discussed separately, hindering cross-disciplinary understanding.
This review organizes and integrates these approaches, positioning them within the value chain of biomedical R&D. It provides a unified framework for cross-disciplinary discussion and offers researchers and practitioners comprehensive coverage from principles to applications and implementation procedures.
Main Contents
- Foundational Principles: Explanation of Bayesian optimization (BO) and evolutionary algorithms (EA)
- Life Science-Specific Challenges: Experimental noise, sample constraints, and safety considerations
- R&D Applications: Five phases covering molecular design, cell and genetic engineering, upstream processes, downstream processes, and clinical applications
- Practical Guidance: Experimental design, parameter settings, and implementation support
- Future Perspectives: Foundation model integration, expansion of multi-objective optimization, autonomous robotics, and regulatory compliance
The appendix includes 56 reference papers in Excel format for research teams and organizations.
Paper Information
- Title: Black-box optimization in immunology and beyond: A practical guide to algorithms and future directions
- Authors: Takanori Kawabata, Taku Tsuzuki, Tsuyoshi Tatsukawa, Kota Matsui, Eiryo Kawakami
- Journal: Allergology International (Review, Open Access)
- Publication Date: September 22, 2025 (Online ahead of print)
- DOI: 10.1016/j.alit.2025.08.006
Related Articles
Won Grand Prix in the 7th IP BASE AWARD Startup Category Hosted by the Japan Patent Office
On March 3, 2026, Epistra Inc. won the Grand Prix in the startup category at the '7th IP BASE AWARD' ceremony hosted by the Japan Patent Office.
Jikkenigaku Special Issue 'AI and Data-Driven Drug Discovery Research' Published — CTO Tsuzuki Authors Chapter on AI-Driven Drug Target Discovery
In 'Jikkenigaku Special Issue: AI and Data-Driven Drug Discovery Research' published by Yodosha, our CTO Taku Tsuzuki authored a chapter on AI-driven knowledge mining for drug target discovery.
Speaking Engagement: Delivered Keynote at the 10th Cell Manufacturing Kotozukuri Symposium
On March 4, 2026, CEO Yosuke Ozawa delivered a keynote speech on optimizing cell manufacturing processes using AI and robotics at the '10th Cell Manufacturing Kotozukuri Symposium' hosted by Osaka University.